Advertisement
Screener

Connect Biopharma Holdings Limited (CNTB) Restructuring Charges

2.8 / 5 stars · 68/120 Roast Me

Connect Biopharma Holdings Limited Restructuring Charges

Connect Biopharma Holdings Limited (CNTB) reported Restructuring Charges of $3.20 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:RestructuringCharges · last filed 2026-03-31

  • Connect Biopharma Holdings Limited restructuring charges for the quarter ending 2024-12-31 was $0.00.
  • Connect Biopharma Holdings Limited restructuring charges for the quarter ending 2024-09-30 was $1.80M.
  • Connect Biopharma Holdings Limited restructuring charges for the quarter ending 2024-06-30 was $1.40M.
  • Connect Biopharma Holdings Limited restructuring charges for fiscal 2024 was $3.20M.
Period endRestructuring Charges 3 monthRestructuring Charges 6 monthRestructuring Charges 9 monthRestructuring Charges 12 month
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$1.80M
derived: sum of 2 quarters · filed 2026-03-31
$3.20M
derived: sum of 3 quarters · filed 2026-03-31
$3.20M
10-K · filed 2026-03-31
2024-09-30$1.80M
10-Q · filed 2025-11-12
$3.20M
derived: sum of 2 quarters · filed 2025-11-12
$3.20M
10-Q · filed 2025-11-12
2024-06-30$1.40M
10-Q · filed 2025-08-13
$1.40M
10-Q · filed 2025-08-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Yarrow Bioscience, Inc. (YARW)United States$0.070B
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76
TENAX THERAPEUTICS, INC. (TENX)United States$0.071B-7.17
PMV Pharmaceuticals, Inc. (PMVP)United States$0.071B-0.95
Lunai Bioworks Inc. (LNAI)United States$0.072B-0.11
XBiotech Inc. (XBIT)United States$0.066B-1.56
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41
Cingulate Inc. (CING)United States$0.073B-2.64
HYPERION DEFI, INC. (HYPD)United States$0.065B
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57